Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
Net Income (Common)
Formosa Laboratories Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Net Income (Common)
NT$392.9m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
16%
|
CAGR 10-Years
5%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Net Income (Common)
NT$1B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
3%
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Net Income (Common)
NT$399.4m
|
CAGR 3-Years
26%
|
CAGR 5-Years
9%
|
CAGR 10-Years
-6%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Net Income (Common)
NT$484.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Net Income (Common)
NT$4.3B
|
CAGR 3-Years
43%
|
CAGR 5-Years
49%
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Net Income (Common)
NT$847.6m
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
10%
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Net Income (Common)?
Net Income (Common)
392.9m
TWD
Based on the financial report for Sep 30, 2024, Formosa Laboratories Inc's Net Income (Common) amounts to 392.9m TWD.
What is Formosa Laboratories Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
5%
Over the last year, the Net Income (Common) growth was 46%. The average annual Net Income (Common) growth rates for Formosa Laboratories Inc have been -33% over the past three years , 16% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet